Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector-Reference-Cited by-同舟云学术

Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector

Published:2006-12-15 Issue:12 Volume:194 Page:1638-1649
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Catanzaro Andrew T.,Koup Richard A.,Roederer Mario,Bailer Robert T.,Enama Mary E.,Moodie Zoe,Gu Lin,Martin Julie E.,Novik Laura,Chakrabarti Bimal K.,Butman Bryan T.,Gall Jason G. D.,King C. Richter,Andrews Charla A.,Sheets Rebecca,Gomez Phillip L.,Mascola John R.,Nabel Gary J.,Graham Barney S.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/194/12/1638/18011540/194-12-1638.pdf

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trials and recent progress in HIV vaccine development;Functional & Integrative Genomics;2024-08-28

2. Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors;Journal for ImmunoTherapy of Cancer;2024-08

3. Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform;Proceedings of the National Academy of Sciences;2024-02-26

4. Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial;eBioMedicine;2024-02

5. HIV vaccines induce CD8 ⁺ T cells with low antigen receptor sensitivity;Science;2023-12-15